Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 2, Issue , 2012, Pages 98-105

  Tritten, Lucienne ^a   Silbereisen, Angelika ^a   Keiser, Jennifer ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Ancylostoma; Drug combination; Nitazoxanide; Trichuris

Indexed keywords

ALBENDAZOLE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; NITAZOXANIDE; PYRANTEL EMBONATE;

ANCYLOSTOMA CEYLANICUM; ANCYLOSTOMIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HAMSTER; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRICHURIASIS; TRICHURIS MURIS;

EID: 84861465216     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2012.02.004     Document Type: Article

References (50)

1. Abaza H., El-Zayadi A.R., Kabil S.M., Rizk H. Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt. Curr. Ther. Res. 1998, 59:116-121.
2. Anderson V.R., Curran M.P. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs 2007, 67:1947-1967.
3. Barnes E.H., Dobson R.J., Barger I.A. Worm control and anthelmintic resistance: adventures with a model. Parasitol. Today 1995, 11:56-63.
4. Bethony J., Brooker S., Albonico M., Geiger S.M., Loukas A., Diemert D., Hotez P.J. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006, 367:1521-1532.
5. Burnell A.M., Houthoofd K., O'Hanlon K., Vanfleteren J.R. Alternate metabolism during the dauer stage of the nematode Caenorhabditis elegans. Exp. Gerontol. 2005, 40:850-856.
6. Cabada M.M., White A.C. Treatment of cryptosporidiosis: do we know what we think we know?. Curr. Opin. Infect. Dis. 2010, 23:494-499.
7. Campbell W.C. Effect of anti-inflammatory agents on spontaneous cure of Trichinella and Trichuris in mice. J. Parasitol. 1968, 54:452-456.
8. Cassada R.C., Russell R.L. The dauerlarva, a post-embryonic developmental variant of the nematode Caenorhabditis elegans. Dev. Biol. 1975, 46:326-342.
9. Chou T.C. Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J. Theor. Biol. 1976, 59:253-276.
10. de Silva N.R., Brooker S., Hotez P.J., Montresor A., Engels D., Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003, 19:547-551.
11. Evans D.F., Pye G., Bramley R., Clark A.G., Dyson T.J., Hardcastle J.D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988, 29:1035-1041.
12. Favennec L., Jave Ortiz J., Gargala G., Lopez Chegne N., Ayoub A., Rossignol J.F. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment. Pharmacol. Ther. 2003, 17:265-270.
13. Fonseca-Salamanca F., Martinez-Grueiro M.M., Martinez-Fernandez A.R. Nematocidal activity of nitazoxanide in laboratory models. Parasitol. Res. 2003, 91:321-324.
14. Fox L.M., Saravolatz L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 2005, 40:1173-1180.
15. Garside P., Behnke J.M. Ancylostoma ceylanicum in the hamster: observations on the host-parasite relationship during primary infection. Parasitology 1989, 98 Pt 2:283-289.
16. Geary T.G., et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 2010, 40:1-13.
17. Geerts S., Coles G.C., Gryseels B. Anthelmintic resistance in human helminths: learning from the problems with worm control in livestock. Parasitol. Today 1997, 13:149-151; discussion 156.
18. Hemphill A., Mueller J., Esposito M. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin. Pharmacother. 2006, 7:953-964.
19. Hoffman P.S., Sisson G., Croxen M.A., Welch K., Harman W.D., Cremades N., Morash M.G. Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob. Agents Chemother. 2007, 51:868-876.
20. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Sachs S.E., Sachs J.D., Savioli L. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
21. Hotez P.J., Brindley P.J., Bethony J.M., King C.H., Pearce E.J., Jacobson J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 2008, 118:1311-1321.
22. Keiser J., Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 2008, 299:1937-1948.
23. Keiser J., Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv. Parasitol. 2010, 73:197-230.
24. Kopp S.R., Coleman G.T., McCarthy J.S., Kotze A.C. Phenotypic characterization of two Ancylostoma caninum isolates with different susceptibilities to the anthelmintic pyrantel. Antimicrob. Agents Chemother. 2008, 52:3980-3986.
25. Li X., Brasseur P., Agnamey P., Lemeteil D., Favennec L., Ballet J.J., Rossignol J.F. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model. Folia Parasitol. (Praha) 2003, 50:19-22.
26. Manneck T., Haggenmuller Y., Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 2010, 137:85-98.
27. Mascarini-Serra L. Prevention of soil-transmitted Helminth infection. J. Glob. Infect. Dis. 2011, 3:175-182.
28. McConnell E.L., Basit A.W., Murdan S. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in vivo experiments. J. Pharm. Pharmacol. 2008, 60:63-70.
29. Müller J., Hemphill A. Identification of a host cell target for the thiazolide class of broad-spectrum anti-parasitic drugs. Exp. Parasitol. 2011, 128:145-150.
30. Nyunt M.M., Plowe C.V. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clin. Pharmacol. Ther. 2007, 82:601-605.
31. O'Riordan V.B., Burnell A.M. Intermediary metabolism in the dauer darva of the nematode Caenorhabitis elegans-1. Glycolysis, glucogenesis, oxidative phosphorylation and the tricarboxylic acid cycle. Comp. Biochem. Physiol. 1989, 92B:233-238.
32. O'Riordan V.B., Burnell A.M. Intermediary metabolsim in the dauer larva of the nematode Caenorhabditis elegans-II. The glyoxylate cycle and fatty-acid oxidation. Comp. Biochem. Physiol. 1990, 95B:125-130.
33. Olliaro P., Seiler J., Kuesel A., Horton J., Clark J.N., Don R., Keiser J. Potential drug development candidates for human soil-transmitted helminthiases. PLoS Negl. Trop. Dis. 2011, 5:e1138.
34. Ortiz J., Lopez Chegne N., Gargala G., Favennec L. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children form Peru. Trans. R. Soc. Trop. Med. Hyg. 2002, 193-196.
35. Rajasekariah G.R., Deb B.N., Dhage K.R., Bose S. Response of laboratory-adapted human hookworm and other nematodes to ivermectin. Ann. Trop. Med. Parasitol. 1986, 80:615-621.
36. Rajasekariah G.R., Deb B.N., Jones M.P., Dhage K.R., Bose S. Response of pre-adult and adult stages of Trichuris muris to common anthelmintics in mice. Int. J. Parasitol. 1991, 21:697-702.
37. Ray D.K., Bhopale K.K. Complete development of Ancylostoma ceylanicum (Looss, 1911) in golden hamsters, Mesocricetus auratus. Experientia 1972, 28:359-361.
38. Romero Cabello R., Guerrero L.R., Munoz Garcia M.R., Geyne Cruz A. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:701-703.
39. Rossignol J.F., Maisonneuve H. Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections. Am. J. Trop. Med. Hyg. 1984, 33:511-512.
40. Rossignol J.F., Stachulski A.V. Syntheses and antibacterial activities of tizoxanide, an N-(nitrothiazolyl) salicyclamide, and its O-aryl glucuronide. J. Chem. Res. (S) 1999, 44-45.
41. Silbereisen A., Tritten L., Keiser J. Exploration of novel in vitro assays to study drugs against Trichuris spp. J. Microbiol. Methods 2011, 87:169-175.
42. Stepek G., Lowe A.E., Buttle D.J., Duce I.R., Behnke J.M. In vitro and in vivo anthelmintic efficacy of plant cysteine proteinases against the rodent gastrointestinal nematode, Trichuris muris. Parasitology 2006, 132:681-689.
43. Stettler M., Rossignol J.F., Fink R., Walker M., Gottstein B., Merli M., Theurillat R., Thormann W., Dricot E., Segers R., Hemphill A. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. Int. J. Parasitol. 2004, 34:615-624.
44. Tritten L., Silbereisen A., Keiser J. In vitro and in vivo efficacy of monepantel (AAD 1566) against laboratory models of human intestinal nematode infections. PLoS Negl. Trop. Dis. 2011, 5:e1457.
45. Tritten L., Nwosu U., Vargas M., Keiser J. In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum. Acta Trop. 2012, 122:101-107.
46. van den Enden E. Pharmacotherapy of helminth infection. Expert Opin. Pharmacother. 2009, 10:435-451.
47. Wakelin D. The stimulation of immunity and the induction of unresponsiveness to Trichuris muris in various strains of laboratory mice. Z. Parasitenkd. 1970, 35:162-168.
48. WHO, 2011. WHO Model List of Essential Medicines (16th list). WHO, Geneva.
49. Wolstenholme A.J., Fairweather I., Prichard R., von Samson-Himmelstjerna G., Sangster N.C. Drug resistance in veterinary helminths. Trends Parasitol. 2004, 20:469-476.
50. Xue J., Hui-Qing Q., Jun-Ming Y., Fujiwara R., Zhan B., Hotez P., Shu-Hua X. Necator americanus: optimization of the golden hamster model for testing anthelmintic drugs. Exp. Parasitol. 2005, 111:219-223.